Leadless cardiac pacing and wireless CRT represent emerging technologies that may revolutionize cardiac stimulation.
Over the past few years, the field of cardiac stimulation has witnessed the accelerated development of leadless cardiac pacing, a technology first conceived almost 50 years ago. Currently, two fully intracardiac devices allow single-chamber right-ventricular stimulation: the Nanostim™ and Micra™ leadles pacemakers. Both are still undergoing long-term study, but only the latter device is commercially available in Switzerland. The field of cardiac resynchronisation therapy is also exploring leadless technology, with the development of the Wireless-CRT system, although its state of development is less advanced. These technologies, though still in relatively early stages, represent initial steps in a revolution in cardiac stimulation.
No takes yet. Share an insight, caveat, or question.
Dayal et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: